Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PLSM

Pulsenmore Ltd

Feb 12 • 04:00PM ET

5.60

-0.19 -3.28 %

Healthcare • Medical Devices • Israel • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.92	Insider Own	9.85%	Shs Outstand	6.31M	Perf Week	-1.75%
Market Cap	36.40M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.86M	Perf Month	-
Enterprise Value	-48.67M	PEG	-	EPS next Q	-	Inst Own	2.44%	Short Float	0.05%	Perf Quarter	-
Income	-44.00M	P/S	3.91	EPS this Y	-	Inst Trans	0.24%	Short Ratio	0.17	Perf Half Y	-
Sales	9.31M	P/B	0.47	EPS next Y	-	ROA	-31.20%	Short Interest	0.00M	Perf YTD	-23.91%
Book/sh	11.81	P/C	0.42	EPS next 5Y	-	ROE	-45.93%	52W High	10.28 -45.53%	Perf Year	-
Cash/sh	13.34	P/FCF	-	EPS past 3/5Y	-4.70% -51.74%	ROIC	-58.48%	52W Low	5.49 2.00%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	82.94% -	Gross Margin	37.36%	Volatility	5.21% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-5.23	EPS Y/Y TTM	16.77%	Oper. Margin	-459.57%	ATR (14)	0.74	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.44	Sales Y/Y TTM	14.82%	Profit Margin	-472.58%	RSI (14)	23.07	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	7.98	EPS Q/Q	-41.89%	SMA20	-7.39%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.02	Sales Q/Q	-8.07%	SMA50	-7.39%	Rel Volume	0.40	Prev Close	5.79
Employees	63	LT Debt/Eq	0.01	Earnings	-	SMA200	-7.39%	Avg Volume	16.51K	Price	5.60
IPO	Jan 21, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	6,655	Change	-3.28%

Feb-09-26 07:00AM	Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance (PR Newswire)
Feb-02-26 07:13AM	Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center (PR Newswire)
Jan-26-26 07:30AM	Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation (PR Newswire)
Jan-23-26 10:06AM	Pulsenmore to commence trading on Nasdaq (TipRanks)
Jan-21-26 07:30AM	Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S. (PR Newswire)

Pulsenmore Ltd. engages in research and development, production, marketing, and sale of self-scan ultrasound devices for remote clinical diagnosis and screening. It also offers a mobile app that guides the patient through a self-scan and enables online consolation with a clinician; as well as a clinician dashboard that allows clinicians to review scans and interacts with the patient remotely. The company was founded by Elazar Sonnenschein on October 27, 2014 and is headquartered in Omer, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PLSM

Pulsenmore Ltd

Upgrade your FINVIZ experience